BE APART OF THE
CYTOGEN™ is the birthchild of tens of thousands of hours of learning, creating, researching, and understanding how the endocannabinoid system works when supplemented with exogenous cannabinoids like CBD, CBG, THC, and of course, the acidic variants of these botanical compounds.
CYTOGEN™ is also the byproduct of hundreds of health professionals openly discussing best practices and gleaning from the latest research for obscure, hard-to-treat health conditions.
Andrew and René have learned along the way that they could use CBD and other cannabinoids to treat their injuries and health challenges, from traumatic injuries and surgeries to depression and anxiety, from general health and wellness to exercise performance.
The Serafini’s developed CYTOGEN™ to morally and ethically advance the sound therapeutic benefits of CBD, and uniquely provide health professionals with a medically-geared suite of CBD products to treat their patients with.
René worked at the first CBD company in the United States, the company who traveled from state-to-state advocating for CBD legalities, and discovered the legal loopholes in establishing CBD from industrial hemp, legally. Before the 2018 Farm Bill, CBD had to be extracted from the mature stalk and the seed, containing less than 0.3% THC by dry weight and had to be imported from outside of the United States, as hemp was still classified as illegal within the US.
Further propelling the Serafini’s into the world of CBD, Andrew lost his mother to medical negligence in October of 2012 as traditional healthcare modalities and medicines failed her, cutting her life short at the young age of 61. She was healthy one day and gone the next, and her passing largely became the driving force behind Andrew's pursuit for a better way, leading him into the industry with eyes wide open in 2014.
Supporting René's work as a sales manager for HempMeds Px, Andrew's experience as a former firefighter/medic in the United States Air Force became significant as he understood human anatomy and how compounds impact the human body. René was working with all types of health complaints from customers at HempMeds. In most cases, the results were eye-opening and remarkable when clients embraced a cannabinoid protocol to fight their respective health conditions. This was the beginning of an incredible passion and mission for Andrew and René.
GLOBAL HEALTH BRANDS
GLOBAL HEALTH BRANDSMrs. Serafini entered the CBD and medical cannabis space in January 2014. Rene excelled as the top sales executive for HempMeds, leading the team of 12+ FTE’s bringing in several of the largest accounts HempMeds had to date. After nine months, she was recruited as the Chief Development Officer for EVRCBD, Inc., and created and launched a complete line of CBD and CBD/adaptogen blends for a wide-array of health conditions.
Rene and her husband, Andrew Serafini, more recently co-founded C3 Global Biosciences and launched the first Healthcare Professional’s line of medically-geared CBD nutraceutical products in the United States. Working only with physicians, pharmacists and other health providers, Rene led the development team producing products of the highest caliber establishing many of the quality standards for CBD products emerging in the market today. After only nine months of operation, C3 Global Biosciences was acquired by one of the largest CBD companies traded on the Canadian Stock Exchange.
In 2018, Rene co-founded Global Health Brands, makers of CYTOGEN Medicinal Cannabidiol Products approved by ANVISA Health Regulatory Agency, Brazilian Ministry of Health. She currently serves as the Chief Executive Officer.